Disclosed positions

Estimated from their latest filings — positions may have changed since

$1.37M

combined est. value

Stock	Shares	Price	Value	Weight	As of
NVCRNovoCure Ltd	76,343	$17.88	$1.37M	100%	2026-03-02

NVCR

NovoCure Ltd

$1.37M

76,343 sh

All filings on record

Every Form 4 transaction we track for this filer

all 5buys 0sells 2

Stock	Transaction	Date	~6mo later
NVCRNovoCure Ltd	Sell $5.5K · 408 sh	2026-03-02	—
NVCRNovoCure Ltd	Sell $21.2K · 1,555 sh	2026-02-27	—
NVCRNovoCure Ltd	Tax $30.6K · 2,133 sh	2026-01-11	—
NVCRNovoCure Ltd	Tax $36.1K · 2,949 sh	2025-11-04	—
NVCRNovoCure Ltd	Tax $2.2K · 168 sh	2025-11-01	—

NVCRSell

2026-03-02 · NovoCure Ltd

$5.5K

—

NVCRSell

2026-02-27 · NovoCure Ltd

$21.2K

—

NVCRTax

2026-01-11 · NovoCure Ltd

$30.6K

—

NVCRTax

2025-11-04 · NovoCure Ltd

$36.1K

—

NVCRTax

2025-11-01 · NovoCure Ltd

$2.2K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.